Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study.

Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study

The drug uses two synthetic antibodies to bind to sites on the virus's spike proteins (Representational)

Paris:

A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.

The therapy, developed by the US biotech firm Regeneron and given to former US President Donald Trump during his brush with the coronavirus, had previously only been used to treat patients in the early stages of the disease.

But the Recovery trial based in Britain has found the drug is effective in treating some patients with more acute cases of the virus.

The treatment, called REGN-COV2, "reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own", the researchers said in a press release.

The drug uses two synthetic antibodies to bind to sites on the virus's spike proteins, preventing it from infecting cells.

Developed by US firm Regeneron and Swiss lab Roche, it may be a solution for people with compromised immune systems who can't produce enough antibodies on their own -- even if they have been vaccinated or had a previous infection.

"It is the first time that any antiviral treatment has been shown to save lives in hospitalised COVID-19 patients," said Martin Landray, a professor of medicine at Oxford University and one of the study's joint chief investigators.

Researchers looked at 9,800 Covid patients hospitalised between September and May, some of whom were randomly designated to receive antibody treatment in addition to their regular care.

One-third of them -- the main group of interest for the study -- had not developed antibodies against coronavirus at the start of their treatment.

Among those patients, the treatment reduced the likelihood of mortality by one-fifth, as 30 percent of non-treated patients died after a 28-day period compared with 24 percent of patients who got treatment.

While encouraging, scientists not involved in the study highlighted the relatively small number of lives saved as well as the affordability of the treatment.

"The absolute magnitude of benefit in mortality is not large, and it means that a large (possibly 20) number of people have to be treated with the extremely expensive drug for a single death to be prevented," said Stephen Evans of the London School of Hygiene and Tropical Medicine.

He told the Science Media Centre that global calls for access to more affordable vaccines could end up being "repeated for these drugs, which are essentially only available in very rich countries."

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news
VOA Unpacked: Life as a Refugee

VOA Unpacked: Life as a Refugee

VOA looks at where refugees come from, the challenges they face, and the paths they travel to seek asylum

Loch Lomond: Man tells of desperate attempts to save his family who died.

Loch Lomond: Man tells of desperate attempts to save his family who died.

Waris Ali has told Sky News of his desperate attempts to save his wife, their nine-year-old son and a family friend who died in Loch Lomond at the weekend. Edina Olahova, Rana Haris Ali and their friend Muhammad Asim Riaz all lost their lives near...

COVID-19 infections up across the U.S.

COVID-19 infections up across the U.S.

All 50 states are reporting an increase in COVID-19 infections as the Delta variant surges and vaccination rates slow. CBS News' Laura Podesta joined "CBSN AM" with the latest. CBSN is CBS News’ 24/7 digital streaming news service featuring live, ...

Newsom challenger warns of 'unintended consequences' from liberal tax proposal.

Newsom challenger warns of 'unintended consequences' from liberal tax proposal.

San Francisco considers transit fees for drivers who enter busy areas during rush hour. California gubernatorial candidate Major Williams with insight on 'Fox & Friends.' #FoxNews #FoxFriendsFirst Subscribe to Fox News! Watch more Fox News Video: ...

Cuba’s Fight For Freedom: Patria y Vida

Cuba’s Fight For Freedom: Patria y Vida

Are the protests in Cuba a moment in time or the start of a movement? NBC News and Telemundo’s José Díaz-Balart will moderate discussions with those on the front lines fighting for change. Guests include actors, Andy García and Laz Alonso; Enrique...

Watch: Sandstorm Engulfs City In Northwest China

Watch: Sandstorm Engulfs City In Northwest China

A wall of sand standing over 300 feet wreaked havoc on Dunhuang, China, reducing visibility to less than 20 feet across the city. The sandstorm created dangerous driving conditions and forced local police to close major roads amid reduced visibili...